Price Extreme update
As seen on the 24/7 Wall St. homepage on June 25, 2026.
New 52-week high
$243.14
+1.9% vs prior high · 2025-10-01
AbbVie hits a fresh 52-week high at $243.14, marking a new peak for the pharma giant navigating Humira biosimilar headwinds with its next-generation immunology pipeline.
Mentioned: ABBV